Webinar on Residual Neuromuscular Paralysis

Date: 9th May 2019

Time:18:00 -19:00 CET 

Scientific Faculty


Prof Manfred Blobner, Germany


Prof Jennifer Hunter, UK  

Prof Claude Meistelman, France

Scientific Support: 

Prof Heidrun Lewald, Germany

Target Audience

This webinar is aimed at practicing anaesthesiologists of all levels of experience working in the perioperative and ICU setting. 

Key Points of this Webinar

This webinar will enable anaesthesiologists to recognise that:

  • Optimal surgical conditions can only be maintained and guaranteed by quantitative neuromuscular monitoring
  • Correct dosing of reversal agents requires prior knowledge of the degree of residual neuromuscular blockade
  • Only quantitative but not qualitative monitoring provides accurate information about the most commonly occurring residual neuromuscular block with a TOFR between 0.4 and 1.0
  • Quantitative but not qualitative monitoring significantly reduces the number of patients having unidentified residual neuromuscular block after surgery
  • Electromyography (EMG) is the most precise neuromuscular monitoring technique currently available

About this Webinar

Residual paralysis affects up to 40 % (in Europe) of patients undergoing general anaesthesia leading to major POPC like pneumonia, atelectasis, desaturation, increased risk of aspiration and reintubation, prolonged LOS.

The current anaesthesia management to avoid residual paralysis has not yet achieved the optimal practice and often the problem is underestimated or not at all considered. 

Timely, optimal Neuromuscular Blocking Agents and Antagonist delivery, quantitatively monitored block level and solid step by step guidelines may reduce the rate and severity of residual paralysis and its implications.